Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Linde
LIN
|
+$764M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$574M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$418M |
| 4 |
PFPT
Proofpoint, Inc.
PFPT
|
+$344M |
| 5 |
UnitedHealth
UNH
|
+$284M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.28B |
| 2 |
Shopify
SHOP
|
+$370M |
| 3 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$351M |
| 4 |
Microsoft
MSFT
|
+$326M |
| 5 |
RP
RealPage, Inc.
RP
|
+$316M |
Sector Composition
| 1 | Technology | 16.42% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.02% |
| 4 | Consumer Discretionary | 11.76% |
| 5 | Industrials | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Smith & Wesson
SWBI
$414M
| $13.8M | 0.01% |
398,952
+360,311
| +932% | +$12.5M |
|
|
STRE
1077
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
| $13.8M | 0.01% |
+1,421,615
| New | +$13.8M |
|
|
LEGA
1078
DELISTED
Lead Edge Growth Opportunities, Ltd Class A Ordinary Shares
LEGA
| $13.8M | 0.01% |
+1,411,368
| New | +$13.8M |
|
1079
NXP Semiconductors
NXPI
$55.5B
| $13.8M | 0.01% |
67,089
-54,452
| -45% | -$11.2M |
|
1080
Wipro
WIT
$29B
| $13.8M | 0.01% |
3,524,916
+3,435,436
| +3,839% | +$13.4M |
|
1081
Kroger
KR
$45.3B
| $13.8M | 0.01% |
359,130
-1,729,023
| -83% | -$66.2M |
|
1082
Lear
LEA
$5.7B
| $13.7M | 0.01% |
78,164
+49,579
| +173% | +$8.69M |
|
1083
Kontoor Brands
KTB
$4.5B
| $13.6M | 0.01% |
241,877
+236,962
| +4,821% | +$13.4M |
|
|
APGB.U
1084
DELISTED
Apollo Strategic Growth Capital II Units, each consisting of one Class A ordinary share, and one-fifth of one warrant
APGB.U
| $13.6M | 0.01% |
1,364,209
-1,369,660
| -50% | -$13.7M |
|
|
INFN
1085
DELISTED
Infinera Corporation Common Stock
INFN
| $13.6M | 0.01% |
1,336,013
+755,915
| +130% | +$7.71M |
|
1086
Aaon
AAON
$6.71B
| $13.6M | 0.01% |
325,964
+153,423
| +89% | +$6.4M |
|
1087
MannKind Corp
MNKD
$1.69B
| $13.6M | 0.01% |
2,490,785
-386,902
| -13% | -$2.11M |
|
1088
StoneCo
STNE
$4.87B
| $13.5M | 0.01% |
201,791
+47,064
| +30% | +$3.16M |
|
|
GGPI
1089
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
| $13.5M | 0.01% |
+1,385,634
| New | +$13.5M |
|
1090
LendingTree
TREE
$979M
| $13.5M | 0.01% |
63,796
-74,302
| -54% | -$15.7M |
|
1091
Abercrombie & Fitch
ANF
$4.19B
| $13.5M | 0.01% |
290,936
-225,404
| -44% | -$10.5M |
|
1092
Arista Networks
ANET
$180B
| $13.5M | 0.01% |
594,656
+524,816
| +751% | +$11.9M |
|
|
VYGG
1093
DELISTED
Vy Global Growth
VYGG
| $13.4M | 0.01% |
1,350,702
+13,812
| +1% | +$137K |
|
1094
West Fraser Timber
WFG
$6.01B
| $13.4M | 0.01% |
187,441
-13,183
| -7% | -$945K |
|
|
ARTAU
1095
DELISTED
Artisan Acquisition Corp. Units
ARTAU
| $13.4M | 0.01% |
+1,348,063
| New | +$13.4M |
|
1096
Clover Health Investments
CLOV
$1.54B
| $13.4M | 0.01% |
1,007,731
+382,033
| +61% | +$5.09M |
|
1097
McGrath RentCorp
MGRC
$3.04B
| $13.4M | 0.01% |
164,132
+34,523
| +27% | +$2.82M |
|
|
PGRE
1098
Paramount Group
PGRE
$1.58B
| $13.4M | 0.01% |
1,329,170
-1,080,072
| -45% | -$10.9M |
|
|
CLVS
1099
DELISTED
Clovis Oncology, Inc.
CLVS
| $13.4M | 0.01% |
2,304,374
+79,770
| +4% | +$463K |
|
1100
CommScope
COMM
$3.59B
| $13.4M | 0.01% |
626,673
-684,340
| -52% | -$14.6M |
|